1 / 19

Natural History of Type 2 Diabetes

Progressive Pancreatic Failure. Pancreas function. Insulin “efficiency”. “Pre-diabetes” “Metabolic Syndrome”. Insulin secretion. PLASMA GLUCOSE Normal: 99 mg/dl or less Pre-Diabetes: 100-125 mg/dl) Diabetes > 126 mg/dl fasting ); > 200 mg/dl )( PostPrandial ). Post-Meal glucose.

Download Presentation

Natural History of Type 2 Diabetes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Progressive Pancreatic Failure Pancreas function Insulin “efficiency” “Pre-diabetes” “Metabolic Syndrome” Insulin secretion PLASMA GLUCOSE Normal:99 mg/dlor less Pre-Diabetes:100-125 mg/dl) Diabetes>126 mg/dlfasting); >200 mg/dl )(PostPrandial) Post-Meal glucose Fasting glucose Natural History of Type 2 Diabetes Years from diagnosis 0 10 5 15 -10 -5 Onset Diagnosis Pre-diabetes Type 2 diabetes Ramlo-Halsted BA, Edelman SV. Prim Care. 1999;26:771-789 Nathan DM. N Engl J Med. 2002;347:1342-1349

  2. Diabetes 5.02 3.64 3.19 2.4 Cardiovascular Risk in Pre-diabetes Non-Diabetic 7 6 5 4 Relative Risk of MI or Stroke 3 2 1.0 1 0 NondiabeticThroughout 10-14.9 YrBefore Dx >15 YrBefore Dx <10 YrBefore Dx DiabeticThroughout Pre-Diabetes Hu FB, et al. Diabetes Care. 2002;25:1129-1134.

  3. Insulin “Efficiency” Pre-diabetes Plasma membrane Insulin receptor Chemical Signals Glucose (“sugar”) carriers Insulin Glucose carriers move to the surface Carriers insert into cell surface Blood Sugar Blood Sugar enters body GLUT4=glucose transporter 4

  4. “Metabolic” Syndrome Physical Inactivity Aging Insulin Efficient (“resistance”) High Cholesterol Heart Disease Blood Vessel Dysfunction Elevated Blood Pressure High Blood Sugar Obesity Modified from S. Grundy MD

  5. High Waist/Hip (0.95 in men) (0.80 in women) Body Shape Matters!!!“Central” obesity An Index of Abdominal vs Peripheral Obesity Low Waist/Hip (<0.95 in men) (<0.80 in women)

  6. 25 20 15 10 5 0 Waist Measurement and Diabetes Risk Upper 10% WHR Lower 10% WHR Risk (%) 54 55 56 57 58 59 60 61 62 63 64 65 66 67 Age Risk of diabetes mellitus during 13 years in relation to WHR at baseline. Comparison between these in upper and lower 10% of WHR distribution. Larsson. Acta Med Scand Suppl. 1988;723:45-51.

  7. Waist/Hip Ratio and Risk • Men: waist size >40 vs <37 inches • Women: waist size >34 vs <31 inches • ~4-fold greater risk for type 2 diabetes • ~3- to 4-fold greater risk for major cardiovascular event Lean et al. Lancet. 1998;351:853-856.

  8. 15 YES 10 NO 5 0 2 4 6 8 12 0 10 Death Increases with Metabolic Syndrome Heart Disease Deaths Metabolic Syndrome: Cumulative hazard (%) Follow-up (y)

  9. Visceral Fat Distribution: Normal vs Type 2 Diabetes Normal Type 2 Diabetes

  10. To diabetes Diabetes Metabolic Syndrome ? R. Heine MD

  11. Insulin Other Injected meds Combination (two) Medications Single Medication Nutritional Preventive Strategies Diet and exercise Increased Heart Disease Type 2 DiabetesPredicted Treatment Paradigm Years from diagnosis 10 0 5 15 -10 -5 Onset Diagnosis Pre-diabetes Type 2 diabetes

  12. NIH Funded Botanical Research Centers “Your Tax Dollars at work” • Botanical Center for Age-Related Disease • Purdue University/UAB • Botanical Dietary Supplements for Women’s Health • University of Illinois at Chicago • Botanical and Lipids (Cholesterol) • Harvard and Wake Forest Universities • Botanicals and Cancer • Memorial Sloan-Kettering Cancer Center/ • Rockefeller University • Botanicals and Metabolic Syndrome • PBRC-LSU/Rutgers

  13. Russian tarragon Tarragon and Diabetes • Extract of Artemisia dracunculus with antidiabetic properties • Produced from hydroponically grown plants under controlled conditions

  14. Clinical Research: BENCH to BEDSIDE! Years 1-4 Animal Testing to monitor Safety and effectiveness Human Testing in Several Phases Years 1-3 Years 3-5 Cells tested with Experimental Intervention

  15. Are Claims for “over the counter” supplements real?

  16. Botanicals Studied “Eat and Drink the Rainbow”

More Related